Nautilus Biotechnology, Inc.
NAUT
$2.35
$0.020.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.19% | -18.28% | -13.87% | -19.75% | -15.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.43% | -22.80% | -18.99% | -17.76% | -12.79% |
| Operating Income | 14.43% | 22.80% | 18.99% | 17.76% | 12.79% |
| Income Before Tax | 11.53% | 21.67% | 17.46% | 16.53% | 11.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.53% | 21.67% | 17.46% | 16.53% | 11.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.53% | 21.67% | 17.46% | 16.53% | 11.30% |
| EBIT | 14.43% | 22.80% | 18.99% | 17.76% | 12.79% |
| EBITDA | 14.09% | 22.84% | 19.04% | 17.94% | 12.86% |
| EPS Basic | 11.85% | 22.02% | 18.00% | 17.12% | 12.02% |
| Normalized Basic EPS | 11.91% | 23.98% | 17.95% | 17.15% | 11.98% |
| EPS Diluted | 11.85% | 22.02% | 18.00% | 17.12% | 12.02% |
| Normalized Diluted EPS | 11.91% | 23.98% | 17.95% | 17.15% | 11.98% |
| Average Basic Shares Outstanding | 0.39% | 0.46% | 0.68% | 0.71% | 0.81% |
| Average Diluted Shares Outstanding | 0.39% | 0.46% | 0.68% | 0.71% | 0.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |